Novo Nordisk reports data breach, tells clinical trial patients to ‘remain vigilant’

Eric Sagonowsky reports: As cybersecurity threats have proliferated across industries in recent years, biopharma companies have emerged as prominent targets, with intellectual property, patient data and other sensitive information at stake. Now, Novo Nordisk is the latest drug giant to report a data breach. In a Thursday incident notice, Novo said it recently identified a security... Source